Resveratrol and rapamycin: are they anti‐aging drugs?

  title={Resveratrol and rapamycin: are they anti‐aging drugs?},
  author={M. Kaeberlein},
  • M. Kaeberlein
  • Published 2010
  • Biology, Medicine
  • BioEssays
  • Studies of the basic biology of aging have advanced to the point where anti‐aging interventions, identified from experiments in model organisms, are beginning to be tested in people. Resveratrol and rapamycin, two compounds that target conserved longevity pathways and may mimic some aspects of dietary restriction, represent the first such interventions. Both compounds have been reported to slow aging in yeast and invertebrate species, and rapamycin has also recently been found to increase life… CONTINUE READING
    87 Citations

    Topics from this paper

    Development of Novel Anti-aging Drugs
    • 1
    • PDF
    Lipid-lowering fibrates extend C. elegans lifespan in a NHR-49/PPARalpha-dependent manner
    • 22
    • PDF
    The role of autophagy in the regulation of yeast life span
    • 18
    Longevity and aging
    • 84
    • PDF
    mTOR Inhibition: From Aging to Autism and Beyond
    • 37
    • PDF
    Resveratrol in cardiovascular health and disease
    • 208


    Aging Is RSKy Business
    • 31
    Resveratrol in prevention and treatment of common clinical conditions of aging
    • 170
    • PDF
    The Sirtuin family: therapeutic targets to treat diseases of aging.
    • 242
    Substrate-specific Activation of Sirtuins by Resveratrol*
    • 701
    • PDF
    Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
    • 1,440
    • PDF
    Resveratrol: One molecule, many targets
    • 284
    A Low Dose of Dietary Resveratrol Partially Mimics Caloric Restriction and Retards Aging Parameters in Mice
    • 572
    • PDF
    The TOR pathway comes of age.
    • 318
    • PDF
    Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
    • 2,669
    • Highly Influential
    • PDF